Coronavirus | Opeds and editorials

Has India passed the COVID-19 peak?

Since mid-September, the number of daily new COVID-19 cases recorded has been reducing from the peak of 90,000-odd cases. A few days ago, the COVID-19 India National Supermodel Committee, constituted by the Department of Science and Technology, based on mathematical modelling studies, concluded that India had passed the COVID-19 peak in September. It also found that there will be fewer than 50,000 active cases from December and if proper safety protocols continue to be followed, the pandemic can be “controlled by early next year” with “minimal” active symptomatic infections by end-February.

In a conversation moderated by R. Prasad, Gautam Menon (a Professor of Physics and Biology at Ashoka University and co-author of COVID-19 modelling studies) and Giridhara R. Babu (a Professor of Epidemiology at the Public Health Foundation of India, Bengaluru, and a member of the Karnataka COVID-19 Technical Advisory Committee) discuss whether India has gone past the peak. Edited excerpts:

The number of daily new cases recorded has been reducing from the peak of about 90,000 cases since mid-September even as the number of tests done each day remain at about 10,00,000. Does this suggest that the pandemic has peaked in India?

Gautam Menon: I think what it suggests is that in the major cities, and in some districts adjacent to those cities that already have sufficient numbers of people infected, the number of new infections is going down, which is to be expected. I don’t think one can say that a bigger or an equivalent peak is not in store for us, because my feeling is that the virus has not been spreading uniformly in India. There are many districts where the number of cases remains small. So, it’s these cases that we will have to watch out for, especially after the festival season.


Giridhara R. Babu: The most dense areas might have already been affected, whether it’s the metros or the tier-2 and tier-3 cities. While the infection is spreading temporarily from one area to another, we cannot certainly say that the worst is over yet. Until we touch the baseline, which is rock bottom, we will not be able to know whether another peak is visible. In my experience with measles and polio, even a slight deviation from the cohort of susceptible people versus how the infection is spreading will ensure that a bigger peak comes much faster, especially when people have been hiding away from the virus. So, we will have to see how it plays out during the winter and afterwards, especially when people start mixing with young people who can spread the infection to the elderly and to those who have co-morbidities. It is not a single wave at the national level which we should be looking at; instead, we should be looking at the State level. We should also be looking at the data from serological surveys, verbal autopsies and missed deaths from the States that are not reporting well, to understand the real nature of the peak.

Except Telangana, the other southern States have been reporting a high number of daily new cases, while large populous States such as U.P., M.P., and Bihar have reported far fewer cases. How do you explain this enigma?

Giridhara R. Babu: Absence of evidence is not evidence of absence. Just because the southern States or some other States, including some in the north, are reporting more cases does not mean that only these States have circulation going on and other States have controlled it. Saying that only a few States have higher transmission compared to others is a statistical fallacy. This is the biggest trap we have seen in many infectious diseases. Due to integrity of reporting cases, many States get classified as high-risk States. The same thing happened, for instance, in the HIV programme. We should not repeat that mistake. We should build strong and resilient systems of data collection and reporting.

There are many ways of assessing whether a State has already gone past the surge in cases or whether it is yet to surge. One of the key things I would like to see is State-level serological surveys throughout the State, and also pick some infections in the acute phase. Testing randomly throughout the State will help us know the case-to-infection ratio, and comparisons between reported cases versus those who have already developed antibodies. Knowing what proportion of people in the general population have positivity by doing random antigen tests and RT-PCR and verbal autopsies of deaths will tell us whether the State has gone past the surge in cases or is yet to surge.

Comment | Imperatives after India’s September virus peak

Gautam Menon: Data are vital. What we need is much more granular data that will give us a better idea of whether it is just lack of reporting or insufficient testing that is governing these numbers or whether there is a genuine reason to be happy.

But some of these States, like U.P., have been doing a high number of daily tests, yet the cases are low. Is it because of over-reliance on rapid antigen tests or under-reporting?

Gautam Menon: The ratio of RAT to PCR test is fairly high in both Bihar and U.P. The method of who you test and what level you test is certainly an issue. Also, whether the testing is done broadly enough in the general population to pick up certain numbers is a question. As a fraction of the absolute population of the State, those test numbers are not good on their own.

Coronavirus | India has been able to ‘distribute the curve’ of COVID-19 infection due to ‘very effective lockdown’: ICMR

Giridhara R. Babu: Also important is when the testing is done. If testing is increased at a time when the surge in cases has not happened already, or the surge in cases has already happened, the number of people who are actually infected might be low. So, if the tests are increased when prevalence is low, you will obviously pick up fewer numbers. And we don’t know which districts are in which stage of transmission in several States.

The Indian Council of Medical Research’s second sero survey says over 7% of the adult population has been infected and the virus has spread to the rural districts. Is testing really good in rural areas or will these areas see a surge later?

Giridhara R. Babu: I feel that there is disparity in the way we test in metros and urban areas and in rural areas, which is a function of this trend of the health system as such. The ICMR survey gave a clear approximation that the infection has spread to rural areas, at least in the surveyed areas. The rural areas should not be ignored; we will have to do more testing in rural areas to corroborate that. We also need to understand whether the rural dynamics of transmission are similar to urban areas. And that can only be known by doing more sero surveys there. We still don’t know what proportion of people are acutely infected and yet not detected. So it’s a sum total of all these things that will give a clearer picture. Without that kind of granular data, we will not be able to say whether rural areas have missing transmission or not.

Coronavirus | Possibility of second wave in winter season cannot be ruled out, says V.K. Paul

Gautam Menon: From informal reports it does seem like many more people in rural areas are ill than are actually going in to be tested. Also, the delays in getting tested after falling ill, and in getting tested and getting a result, are significant in the progression of the disease from person to person.

The expert committee has projected a minimal number of fresh cases by end-February. Is it correct based on mathematical modelling to project for a period of four months during the pandemic?

Gautam Menon: Well, I would not do that and I would not recommend that anyone does it either with any degree of confidence. I think all one can say is that this particular model with these particular numbers show that cases will come down for three or four months down the line. But we have no reason to believe that those numbers will remain the same, the parameters in that model will remain the same. A much better index is what is the fraction of the population of the country that you think is currently infected. And that will tell you how many more people are there to be infected.

Coronavirus | September accounted for 41.53% of total cases in India

Currently there are about 7.5 lakh active cases but the committee says it will drop to 50,000 in December. Do you think it’s feasible?

Gautam Menon: It could be unusual for that to happen. They believe that 300-400 million people in India are already infected, which seems a little too high to me. I think 200-million plus is probably a reasonable ballpark figure. There are lots of people yet to be infected, a lot of them are in areas that have not been exposed yet. So, at what rate they will get infected is the important question. I suspect that there will be a background of infection as we go towards the next couple of months. It will not dip very significantly at least for the next two or three months.

Giridhara R. Babu: These predictions are good as long as they serve the purpose of planning, ensuring that we are stepping up our resources. But then if they give some kind of robust confidence that all is well and we might be free from this disease beyond December, I don’t think any of us have that kind of optimism yet. I would want to look at seven days average, at the minimum, to understand what is going to happen in the next seven days.

Editorial | A tool for thought: On coronavirus pandemic in India

Gautam Menon: Yes, I agree. I don’t see what the point is of saying that something’s going to happen four months later when we don’t have enough knowledge. A week, two weeks in advance is the best that one can do. I worry that putting such a long horizon serves a political purpose rather than a public health purpose.

The committee has not been able to provide any valid explanation for why India seems to have peaked. What could be the reasons considering that India has gone through various stages of unlock and movement of people has increased?

Giridhara R. Babu: The data suggest that areas that were prone to increased population movement and where people were working even when the lockdown was there and who did not follow the public health regulations were the ones who got the earlier waves of circulation. With the most dense areas having been affected already, it’s only the lesser population density areas which are the next focus. Therefore, the speed at which it will spread is going to be different from what it was earlier. The test positivity is also going down as testing numbers have not majorly decreased. Definitely there seems to be some decrease in cases but since we have not touched the baseline, we can’t be sure that this is over.

Editorial | Pandemic peak: On Finance Ministry's report

What will the combined effect of the festival season, winter, unrestricted movement of people, opening up of business establishments and non-adherence to non-pharmaceutical interventions be on the virus spread?

Giridhara R. Babu: We don’t know what has happened before to actually know what is happening now and to predict what’s going to happen in the future. Let’s assume region A has already had a surge in cases and nearly 40%-50% of the people have been infected. So, even if festivals are celebrated and people congregate, one may not see that kind of a spike in cases in that region. Whereas, in region B, if the earlier surge was not there, the same kind of behaviour might result in big hotspots and many deaths. We don’t know what’s happening at the district level. So we need to make a beginning of trying to understand what is happening in each district to be able to predict which districts require more care. We are not using the data in the wisest manner. That’s my worry.

Coronavirus | Modi cautions nation ahead of festival season

Giridhara R. Babu is a Professor of Epidemiology at the Public Health Foundation of India, Bengaluru, and a member of the Karnataka COVID-19 Technical Advisory Committee; Gautam Menon is a Professor of Physics and Biology at Ashoka University and co-author of COVID-19 modelling studies.

Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Dec 7, 2021 8:13:23 AM |

In This Package
Boosters short: On third COVID-19 vaccination dose
The Omicron response is not making sense
Limited gains: On Omicron risk
Scale up supplies: On Omicron variant
What the Omicron variant means for India
Learning from the best in India’s COVID-19 fight
Focus on full vaccination: On India’s COVID-19 inoculation pace
India needs to sign up for life-course immunisation
Strengthening vaccine trust
A reminder from SARS-CoV-2
The vaccination milestone and a distant goal
Responding to adversity with achievement
Scripting history: On 100 crore COVID-19 vaccine doses
Vigilance, vaccination and endemic COVID-19
A flicker of hope: On declining COVID-19 numbers
Vital relief: On COVID-19 death compensation
A spike: On records and COVID-19 vaccination coverage
Cracking the whip: On Joe Biden’s vaccine mandates
Should children be given COVID-19 jabs?
The lag between jabs: On Covishield gap
Back at school: On student safety
Breakthrough challenge: On vaccines and the virus variants
The prognosis for school reopenings
Effectiveness of vaccines
Kerala’s rising COVID-19 cases explained
Learning safely: On schools reopening
A surfeit of sero surveys
Curbing Delta: On the variant that drives India’s COVID-19 infections
Focusing on diseases sidelined by COVID-19
Lessons from India’s all-cause mortality data
Safe at school: On getting students back on campus
The importance of the booster dose to plan ahead
A call for improving civil registration systems
Pandemic of distrust: On resisting COVID-19 vaccination
Vaccinating the young: On priority groups
A serosurvey template for the whole of India
Making decisions under stress
Dealing with denial: On playing down the COVID-19 tragedy
A cardinal omission in the COVID-19 package
Rising again: On global rise of fresh COVID-19 cases
Ramping up supply: On COVID-19 vaccination woes
Upholding trust in vaccination
Caution and optimism: On preventing the third wave
Countering the next wave of COVID-19
Stopping the surge: On unlock and the next COVID-19 wave
A welcome spike: On India’s COVID-19 vaccination record
A time to give: On ex-gratia compensation to families of COVID-19 victims
Focus on COVID-19 estimated deaths
What needs to be done with vaccines
Counting the dead: On measuring excess deaths
Refocused vaccination campaigns are possible
Bring genomic sequencing into the pandemic fight
Preparing for the next COVID-19 wave
Connecting the dots to mitigate a third wave
The red flags on the trail of the virus
Behaviorial change can reduce transmission
Adverse changes, federalism imperilled
Close the vaccination gap, in global lockstep
Only a global effort can tame COVID-19
Addressing vaccine hesitancy
Naturally, selection: On vaccinating the vulnerable in 18+ group
Vaccination is our only weapon
Extending safety: On deferring second dose of COVID-19 vaccine
The AIDS fight offers a COVID vaccine patent pathway
The basics of an effective vaccine policy
Using all options: On Covaxin licensing
State action: On Centre’s role in COVID-19 fight
COVID mishandling foretold in the Budget
A matter of concern: On Indian coronavirus variant
Vaccine skirmishes: On production of COVID-19 vaccine
Lockdown gains: On need to augment health system
Social murder and the missing state
A CT scan for COVID merits a word of caution
To stop a third wave, India has to mask up
Is the government committed to vaccine equity?
Salutary steps: On Election Commission norms to curb COVID-19 spread
Shortage and wastage: On cutting vaccine wastage
Gasping for air, gasping for answers
Misinformed and misleading
Right priorities: On U.S. COVID-19 aid to India
A patently wrong regime
Tips for managing COVID-19 at home: the dos & don’ts
Undermining ‘vaccination for all’
Another wave spells more nutrition loss
Unfair and dangerous: On vaccine inequity
Viral load: On lockdowns, lives and livelihoods
The road ahead in India’s augmented vaccination drive
Infernal infernos: On hospital fires amid the pandemic
Too little: On the Election Commission’s COVID-19 curbs
India’s COVID crisis — when difficult became worse
A descent into disillusionment and chaos
Open and safe: On Modi government’s vaccination policy
A recipe for vaccine inequity
Vaccine diplomacy that needs specific clarifications
On the trail of the second wave’s dynamics
How can India contain the second wave?
Lessons from the first wave
Examination priorities: On annual exams amid the pandemic
The secrecy around deaths after vaccination
Indian universities need immediate vaccination
Lessons from COVID-19
The second wave: On why new COVID-19 vaccines should be cleared
Weighing in on the saga of a vaccine
Rising poverty: On pandemic-induced disparities
A booster shot for India’s vaccination plan
Allaying concerns: On public trust and vaccination programmes
A moral test: On the vaccine divide
Efficacious too: On Covaxin
Sustaining the drive: On COVID-19 vaccination phase 2
Vaccine inequities: On need to vaccinate all above 45
Addressing vaccine reluctance and policy hesitancy
Redefining the exit plan for COVID-19
Boosting confidence: On need for efficient use of COVID-19 vaccine stocks
Opening up the vaccine market
Origin and spread: On the source of SARS-CoV-2
New questions: On COVID-19 infecting one-fifth of Indian population
A year on, mind the gaps in the pandemic response
Should Board exams be conducted in one go this year?
No to vaccine nationalism, yes to global cooperation
Tempered optimism: On India’s sliding COVID-19 graph
The best shot against COVID-19
More vaccines than takers
Managing the rollout: On addressing vaccine hesitancy
Injecting confidence: On India’s COVID-19 vaccination drive
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
You are reading
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story